Advances in Alzheimer’s Therapies focuses on the latest breakthroughs in therapeutic approaches for Alzheimer’s disease. With a growing understanding of the disease’s underlying mechanisms, researchers and clinicians are making significant strides in developing targeted treatments. This includes pharmacological innovations, immunotherapies, gene-based approaches, and non-pharmacological interventions aimed at slowing disease progression, managing symptoms, and improving quality of life for patients and caregivers.
Track 4:1 Immunotherapy and Monoclonal Antibodies
Track 4:2 Gene Therapy and RNA-Based Treatments
Track 4:3 Neuroprotective and Neurorestorative Agents
Track 4:4 Combination Therapies
Track 4:5 Non-Pharmacological Therapeutic Innovations
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
